Sandeep Laumas, CEO, Executive Chairman at INNOVATE BIOPHARMACEUTICALS, INC. (INNT), bought 4,000 shares at $1.15 ($5K) on 2019-06-28, disclosed to the SEC on 2019-07-01.
Open-market purchase of $5k INNT by CEO, Executive Chairman. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Something here stands out, but not much.
| Filing → |
| INNT | BUY | 2019-05-23 | $7K | — | Filing → |
| INNT | BUY | 2018-12-03 | $8K | — | Filing → |
| INNT | BUY | 2018-11-29 | $8K | — | Filing → |